PORTSMOUTH, N.H.–(BUSINESS WIRE)–As part of its ongoing effort to improve patient outcomes for spinal procedures and reduce non-routine patient discharges for its hospital customers, Salient Surgical Technologies, Inc. today unveiled the Aquamantys™ Epidural Vein Sealer (EVS) bipolar device at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting in Las Vegas, NV.
The EVS is designed to address the challenging anatomy in minimally invasive spine surgery and is the latest product introduction on Salient’s proprietary Aquamantys platform. The EVS employs Transcollation™ advanced energy technology to significantly reduce bleeding in hard-to-reach areas. Reducing blood loss improves visualization for the surgeon, can result in improved clinical outcomes for the patient and may result in lower costs to the hospital.
Transcollation technology is a calibrated fusion of radiofrequency energy and saline that gently seals bleeding tissues, vessels and bone at the surgical site. The innovation of the EVS is the ability to deliver Transcollation technology through miniaturized electrodes, which provide direct and precise compression of epidural veins around critical structures. The EVS is used with the same Aquamantys System Generator as Salient’s standard 2.3 and 6.0 Bipolar Sealer devices.